Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?

Bo Gronlund, Claus Høgdall, Jørgen Hilden, Svend A Engelholm, Estrid V S Høgdall, Heine H Hansen

75 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab